Therapeutic Goods Administration (TGA), Australian Government Department of Health, Disability and Ageing
Is Exenatide legal in Australia?
Not approvedTGA assessed Byetta and Bydureon (2013), but a search of the ARTG on 29 Sep 2026 finds no current exenatide entry.
Not approved as a medicine here.
The TGA published an assessment report for Byetta and Bydureon (exenatide) in 2013, so it was approved in the past. A keyword search of the ARTG on 29 September 2026 returned no matching results, and no exenatide application appears on the TGA under-evaluation list (updated 21 September 2026). Exenatide is a GLP-1 receptor agonist, so the general ban on compounding GLP-1 receptor agonist analogues applies to any pharmacy activity. Anyone needing it would need an unapproved-medicine access route.
Last verified 2026-09-29 · how we verify
Exenatide elsewhere
Sources (4)
- 01AusPAR: Byetta / Bydureon (exenatide)Therapeutic Goods Administration (TGA) · 2013-03-27 · accessed 2026-09-29
- 02ARTG keyword search for 'exenatide' (no matching results)Therapeutic Goods Administration (TGA) · 2026-09-29 · accessed 2026-09-29
- 03Prescription medicines under evaluation (last updated 21 September 2026)Therapeutic Goods Administration (TGA) · 2026-09-21 · accessed 2026-09-29
- 04Manufacturing, supplying and advertising compounded medicines lawfullyTherapeutic Goods Administration (TGA) · 2026-05-14 · accessed 2026-09-29